Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Global Regulatory News (JARA)

Share Price Information for Jpmorgan Global (JARA)

Share Price is delayed by 15 minutes
Get Live Data
77.00    -2.00 (-2.53%)
Bid:
77.00
Ask:
78.00
Spread: 1.00 (1.299%)
Market Cap: £22.07m
JARA Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Global Share Chart

Kepler Trust Intelligence: Flash Update

10 May 2023 14:20

RNS Number : 9890Y
JPMorgan Global Core Real Assets Ld
10 May 2023
 

JPMorgan Global Core Real Assets: Flash Update

10/05/2023

JARA's diversification should bring resilience in troubled markets…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADSEFFPDEFA
Date   Source Headline
1st Jun 202611:34 amRNSTotal Voting Rights
12th May 20265:12 pmRNSDirector/PDMR Shareholding
8th May 20264:13 pmRNSDirector/PDMR Shareholding
8th May 20264:12 pmRNSDirector/PDMR Shareholding
7th May 20269:09 amRNSMonthly Portfolio Update
5th May 20261:14 pmRNSHolding(s) in Company
1st May 20267:00 amRNSFOURTH COMPULSORY PARTIAL REDEMPTION OF SHARES
15th Apr 20267:00 amRNSFOURTH COMPULSORY PARTIAL REDEMPTION OF SHARES
7th Apr 20267:00 amRNSMonthly Portfolio Update
16th Mar 202610:22 amRNSQuarterly Net Asset Value and Portfolio Update
10th Mar 20263:32 pmRNSDirector/PDMR Shareholding
5th Mar 20265:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20262:17 pmRNSClosed period notification
2nd Mar 202612:56 pmRNSHolding(s) in Company
23rd Feb 20265:07 pmRNSHolding(s) in Company
20th Feb 20269:45 amRNSMonthly Portfolio Update
17th Feb 20265:38 pmRNSDirector/PDMR Shareholding
16th Feb 202612:29 pmRNSDirector/PDMR Shareholding
12th Feb 202610:48 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSTHIRD COMPULSORY PARTIAL REDEMPTION OF SHARES
26th Jan 20265:50 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSTHIRD COMPULSORY PARTIAL REDEMPTION OF SHARES
12th Jan 20265:07 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSMonthly Portfolio Update
11th Dec 202510:14 amRNSQuarterly NAV and Portfolio Update
28th Nov 20257:00 amRNSHalf-year Financial Report
18th Nov 20257:00 amRNSMonthly Portfolio Update
14th Oct 20257:00 amRNSMonthly Portfolio Update
17th Sep 20251:14 pmRNSBlock listing Interim Review
17th Sep 202512:57 pmRNSClosed Period Notification
17th Sep 20257:00 amRNSQUARTERLY NET ASSET VALUE AND PORTFOLIO UPDATE
5th Sep 20259:15 amRNSDirector/PDMR Shareholding
1st Sep 20255:11 pmRNSHolding(s) in Company
1st Sep 202510:12 amRNSTotal Voting Rights
29th Aug 202510:25 amRNSHolding(s) in Company
28th Aug 20253:58 pmRNSResult of AGM
27th Aug 202511:12 amRNSDirector Declaration
19th Aug 20255:38 pmRNSHolding(s) in Company
15th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 20254:35 pmRNSDirector/PDMR Shareholding
11th Aug 20254:18 pmRNSDirector/PDMR Shareholding
11th Aug 20254:17 pmRNSDirector/PDMR Shareholding
8th Aug 20257:00 amRNSSECOND COMPULSORY PARTIAL REDEMPTION OF SHARES
7th Aug 20257:00 amRNSMonthly Portfolio Update
22nd Jul 20257:00 amRNSSECOND COMPULSORY PARTIAL REDEMPTION OF SHARES
9th Jul 20257:00 amRNSMonthly Portfolio Update
3rd Jul 202511:30 amRNSHolding(s) in Company
2nd Jul 20257:00 amRNSQuarterly Net Asset Value & Portfolio Update
30th Jun 20253:49 pmRNSFinal results for the year ended 28 February 2025
24th Jun 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.